The HIV Vaccine: Discontinuation of Trials Essay

Exclusively available on Available only on IvyPanda® Made by Human No AI

The HIV vaccine trial (Merck V520-023 study) was conducted on people around the globe with the aim of preventing HIV condition. Additionally, Dieffenbach and Fauci (2020) claim that the STEM study also explored the prospect of lowering the amount of HIV infection in people who already suffer from the illness. The National Institutes of Health (2007) summarize that the origin of the vaccine already implies the impossibility of treating disorders due to its synthetic production. Therefore, the latter goal was not met during the study, which means that the trial still aimed to analyze whether vaccinated participants would contract the HIV infection.

Having briefly researched the origin and description of the Merck V520-023 study, it is safe to say that it goes against the ethical principles of healthcare. First of all, not only did the medics who conducted the trial likely put the lives of 3000 participants at risk, they definitely compromised their patients’ safety (Schofield et al., 2021). The lack of research and testing of the HIV vaccine was evident, and the outcomes of the trial could be either adverse or outstanding. The main problem here is that no one could predict how the vaccine would affect the participants, so this trial should not have occurred at all without prior testing and analysis. Moreover, it has not been mentioned whether the participants signed an informed consent about possible risks of getting vaccinated. Therefore, it could be another ethical issue in this STEM study.

The in-depth description of the STEM study clearly states that the risks of participants getting HIV because of the vaccines were zero. In fact, the National Institutes of Health (2007) state that since the medication is produced with synthetic material, it is not feasible for people to contract HIV after being vaccinated. Therefore, the primary benefit of this study is that people could get immune to the HIV infection, provided the vaccine worked. Yet it is safe to assume that the inefficacy or failure of the medication could lead to negative repercussions for participants’ health. For instance, the vaccine could provoke other diseases and simply contribute to complications with health. Overall, conducting a vaccine trial on 3000 people before testing the medication properly was not only risky but foolish, considering it could endanger the lives of many innocent individuals.

Naturally, the lack of reliable data to prove the efficacy of the vaccine, comparing results of medication injection and placebo, led to the STEM study being terminated. Even though the practice of including a placebo group in the survey is typical in medical experimentations, it is often called unethical (Physicians Committee for Responsible Medicine, 2022). As a matter of fact, it is expected to use the standard treatment (in this case, vaccine) as an active control in the study to avoid unnecessary risks to the placebo group. Besides, it is ethically concerning that the STEM study selected only men who have sex with men as participants for this experiment, excluding heterosexual candidates (National Institutes of Health, 2007). Therefore, it is unfair of the study coordinators to assume that most homosexual males can get the HIV infection and not the individuals who are heterosexual. Yet the exclusion of heterosexual participants may seem ethically problematic as well, considering that they did not have access to receiving the vaccine and did not have an opportunity to develop immunity to HIV.

References

Dieffenbach, C. W., & Fauci, A. S. (2020). The search for an HIV vaccine, the journey continues. Journal of the International AIDS Society, 23(5).

National Institutes of Health. (2007). National Library of Medicine. Web.

Physicians Committee for Responsible Medicine. (2022). Web.

Schofield, G., Dittborn, M., Selman, L. E., & Huxtable, R. (2021). Defining ethical challenge(s) in healthcare research: A rapid review. BMC Medical Ethics, 22(1).

More related papers Related Essay Examples
Cite This paper
You're welcome to use this sample in your assignment. Be sure to cite it correctly

Reference

IvyPanda. (2023, July 3). The HIV Vaccine: Discontinuation of Trials. https://ivypanda.com/essays/the-hiv-vaccine-discontinuation-of-trials/

Work Cited

"The HIV Vaccine: Discontinuation of Trials." IvyPanda, 3 July 2023, ivypanda.com/essays/the-hiv-vaccine-discontinuation-of-trials/.

References

IvyPanda. (2023) 'The HIV Vaccine: Discontinuation of Trials'. 3 July.

References

IvyPanda. 2023. "The HIV Vaccine: Discontinuation of Trials." July 3, 2023. https://ivypanda.com/essays/the-hiv-vaccine-discontinuation-of-trials/.

1. IvyPanda. "The HIV Vaccine: Discontinuation of Trials." July 3, 2023. https://ivypanda.com/essays/the-hiv-vaccine-discontinuation-of-trials/.


Bibliography


IvyPanda. "The HIV Vaccine: Discontinuation of Trials." July 3, 2023. https://ivypanda.com/essays/the-hiv-vaccine-discontinuation-of-trials/.

If, for any reason, you believe that this content should not be published on our website, please request its removal.
Updated:
This academic paper example has been carefully picked, checked and refined by our editorial team.
No AI was involved: only quilified experts contributed.
You are free to use it for the following purposes:
  • To find inspiration for your paper and overcome writer’s block
  • As a source of information (ensure proper referencing)
  • As a template for you assignment
Privacy Settings

IvyPanda uses cookies and similar technologies to enhance your experience, enabling functionalities such as:

  • Basic site functions
  • Ensuring secure, safe transactions
  • Secure account login
  • Remembering account, browser, and regional preferences
  • Remembering privacy and security settings
  • Analyzing site traffic and usage
  • Personalized search, content, and recommendations
  • Displaying relevant, targeted ads on and off IvyPanda

Please refer to IvyPanda's Cookies Policy and Privacy Policy for detailed information.

Required Cookies & Technologies
Always active

Certain technologies we use are essential for critical functions such as security and site integrity, account authentication, security and privacy preferences, internal site usage and maintenance data, and ensuring the site operates correctly for browsing and transactions.

Site Customization

Cookies and similar technologies are used to enhance your experience by:

  • Remembering general and regional preferences
  • Personalizing content, search, recommendations, and offers

Some functions, such as personalized recommendations, account preferences, or localization, may not work correctly without these technologies. For more details, please refer to IvyPanda's Cookies Policy.

Personalized Advertising

To enable personalized advertising (such as interest-based ads), we may share your data with our marketing and advertising partners using cookies and other technologies. These partners may have their own information collected about you. Turning off the personalized advertising setting won't stop you from seeing IvyPanda ads, but it may make the ads you see less relevant or more repetitive.

Personalized advertising may be considered a "sale" or "sharing" of the information under California and other state privacy laws, and you may have the right to opt out. Turning off personalized advertising allows you to exercise your right to opt out. Learn more in IvyPanda's Cookies Policy and Privacy Policy.

1 / 1